CASE DISCUSSION
Management of Cystic Fibrosis
Presented India by Dr. Siva Kumar ReddyViews
6,846
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
Cystic fibrosis is a chronic, progressive disease that primarily affects the respiratory and digestive systems. It is caused by a gene mutation leading to dysfunction of the cystic fibrosis transmembrane conductance regulator (CFTR) protein. While there is no cure for CF, the goals of treatment are...
Case Summary
- Cystic Fibrosis (CF) is a life-limiting, autosomal recessive disease impacting multiple systems, notably the lungs and gastrointestinal tract. It's more prevalent in Western populations, less common in India and Africa. The disease stems from a mutation in the CFTR gene, which affects chloride and water transport across cell membranes.
Speaker Profile
Dr. Siva Kumar Reddy
Alumni - Sri Ramachandra Medical College and Research InstituteDr. L. Siva Kumar Reddy is a Senior Consultant in Critical Care Medicine at AIG Hospitals (Asian Institute of Gastroenterology), Gachibowli, Hyderabad. He holds an MD and is one of the few physicians in India in critical care with a DM (Doctorate of Medicine) qualification in the specialty. He has 15 years of experience and has trained at multiple prestigious health care universities in India. His clinical areas of expertise include ARDS, sepsis management, critical care ultrasound, and critical care nephrology. He is an AHA-certified Instructor for ACLS/BLS, an instructor for BASIC (from the Chinese University of Hong Kong), and is well-versed in acute care resuscitation protocols. He is frequently invited as a faculty expert for demonstrations and lectures at major state and national ISCCM conferences. He is an active researcher and co-author in the ISCCM Textbook of Critical Care Medicine.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.